Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioCyto is a biotechnology company specializing in high-throughput single-cell analysis and sorting technologies to accelerate drug discovery and development. The company provides advanced platforms for the screening of therapeutic antibodies and the characterization of cell therapies, particularly focusing on oncology and immunology. By integrating microfluidics with high-resolution imaging and bioinformatics, BioCyto enables the precise identification of rare cell populations and functional lead candidates. Their services and products cater to pharmaceutical companies and research institutions seeking to streamline the early stages of biologics development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioCyto.